InvestorsHub Logo
Followers 7
Posts 1233
Boards Moderated 0
Alias Born 09/23/2009

Re: None

Wednesday, 08/19/2015 9:55:00 AM

Wednesday, August 19, 2015 9:55:00 AM

Post# of 27424
Kraus Sales

Why would this guy be selling if CTSO is on the brink of FDA approval in the next 1-2 years? Does anybody find this scary? This guy has insider information for the stock and the metrics surrounding treatment with Cytosorb and he is selling all of his stock? The plan he setup basically sells a fixed amount of shares at fixed periods over the course of 1+ years. That is the only way insiders can "get out" of a stock without being accused of selling/buying based on their non public information.

Does this bother anyone? I would think anyone would be holding if they worked for the company and things were expected to go well.

It is my honest opinion that I feel the company is having extreme difficulty proving that the reduction in cytokines equates to the patient surviving or reducing their days in the ICU on a statistical significant level. I have been around for 5-6 years and it has been the same story since 8/19/2010. There isn't overwhelming data yet that draws the conclusion that mortality is reduced through the use of this device on a statistical significant level.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News